Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
02 10 2021
Historique:
received: 13 11 2020
accepted: 15 01 2021
pubmed: 2 2 2021
medline: 22 12 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

To determine quantitative SI joint MRI lesion cut-offs that optimally define a positive MRI for inflammatory and structural lesions typical of axial SpA (axSpA) and that predict clinical diagnosis. The Assessment of SpondyloArthritis international Society (ASAS) MRI group assessed MRIs from the ASAS Classification Cohort in two reading exercises where (A) 169 cases and 7 central readers; (B) 107 cases and 8 central readers. We calculated sensitivity/specificity for the number of SI joint quadrants or slices with bone marrow oedema (BME), erosion, fat lesion, where a majority of central readers had high confidence there was a definite active or structural lesion. Cut-offs with ≥95% specificity were analysed for their predictive utility for follow-up rheumatologist diagnosis of axSpA by calculating positive/negative predictive values (PPVs/NPVs) and selecting cut-offs with PPV ≥ 95%. Active or structural lesions typical of axSpA on MRI had PPVs ≥ 95% for clinical diagnosis of axSpA. Cut-offs that best reflected a definite active lesion typical of axSpA were either ≥4 SI joint quadrants with BME at any location or at the same location in ≥3 consecutive slices. For definite structural lesion, the optimal cut-offs were any one of ≥3 SI joint quadrants with erosion or ≥5 with fat lesions, erosion at the same location for ≥2 consecutive slices, fat lesions at the same location for ≥3 consecutive slices, or presence of a deep (i.e. >1 cm depth) fat lesion. We propose cut-offs for definite active and structural lesions typical of axSpA that have high PPVs for a long-term clinical diagnosis of axSpA for application in disease classification and clinical research.

Identifiants

pubmed: 33523107
pii: 6125390
doi: 10.1093/rheumatology/keab099
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4778-4789

Subventions

Organisme : Assessments in SpondyloArthritis international Society (ASAS)
Organisme : National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC)

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Walter P Maksymowych (WP)

Department of Medicine, University of Alberta, Edmonton.
CARE Arthritis.

Robert G Lambert (RG)

Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Canada.
Medical Imaging Consultants, Edmonton, Canada.

Xenofon Baraliakos (X)

Rheumazentrum Ruhrgebiet Herne, Ruhr-University, Bochum, Germany.

Ulrich Weber (U)

Department of Rheumatology, Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg.
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Pedro M Machado (PM)

Department of Rheumatology, University College London Hospitals NHS Foundation Trust.
Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust.
Centre for Rheumatology and MRC Centre for Neuromuscular Diseases, University College London, London, UK.

Susanne J Pedersen (SJ)

Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, Denmark.

Manouk de Hooge (M)

VIB Inflammation Research Center, Ghent University.
Rheumatology Department, Ghent University Hospital, Ghent, Belgium.

Joachim Sieper (J)

Department of Rheumatology, Charité - Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin.

Stephanie Wichuk (S)

Department of Medicine, University of Alberta, Edmonton.

Denis Poddubnyy (D)

Department of Rheumatology, Charité - Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin.

Martin Rudwaleit (M)

Klinikum Bielefeld, Bielefeld.
Department of Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Désirée van der Heijde (D)

Leiden University Medical Centre, Leiden.

Robert Landewe (R)

Department of Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam.
Atrium Medical Center, Heerlen, the Netherlands.

Iris Eshed (I)

Sheba Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.

Mikkel Ostergaard (M)

Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH